Synapse News

7 of 31

Ontario economic development minister Announces $40M investment in Hamilton’s OmniaBio (video)

Vic Fedeli, Minister of Economic Development, Job Creation and Trade, was joined by Prabmeet Sarkaria, President of the Treasury Board, and Donna Skelly, MPP for Flamborough—Glanbrook, to make an announcement at McMaster Innovation Park

March 31, 2022 | Alex Muggah

Invest Ontario Supports New Biomanufacturing Facility in Hamilton

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson’s and diabetes. OmniaBio, a Canadian cell and gene…

March 31, 2022 | Alex Muggah

New gene- and cell-therapy manufacturing facility to launch in Hamilton with $580-million commitment

Ontario says it will provide a $40-million loan to the Centre for Commercialization of Regenerative Medicine for its planned $580-million Hamilton facility where life-science companies can develop and commercialize cell and gene therapies. The CCRM, a non-profit industry group, said Thursday that the facility will be run by a new subsidiary…

March 31, 2022 | Alex Muggah

Triumvira Immunologics Completes Extension of Series A Financing, for Total Round of Approximately $100 Million

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced the completion of an extension of its Series A financing, bringing the total round to approximately $100 million. The Series A…

March 17, 2022 | Alex Muggah

Dr. Marc Jeschke named new VP of Research at HHS

Hamilton Health Sciences Centre has announced the appointment of Dr. Marc Jeschke (pictured) as vice president of research at HHS, commencing on June 1, 2022. Dr. Jeschke brings world-renowned expertise to the organization in the field of translational research through which basic scientific and medical research are brought into day-to-day…

January 26, 2022 | Alex Muggah

McMaster ranked #1 for faculty and graduate student research intensity

McMaster University continues to rank among the country’s most research-intensive universities – for both graduate students and faculty members – in the annual ranking of the country’s Top 50 Research Universities. According to the 2021 Research Infosource rankings released today, McMaster placed first in graduate student research…

January 25, 2022 | Alex Muggah

Bay Area Health Trust supplies Ontario with McMaster Molecular Medium for COVID-19 PCR test kits

Bay Area Health Trust will be supplying Ontario’s provincial labs with its McMaster Molecular Medium (MMM), a molecular transport medium that is a critical component of COVID-19 PCR testing. This is a repeat order of the made-in-Ontario product by the procurement authority representing the Province of Ontario. MMM is on Public Health…

January 25, 2022 | Alex Muggah

Hyivy Health secures $1.1 million in pre-seed funding to ease women’s pelvic health problems

Born from its founder’s own experience with cervical cancer, FemTech startup Hyivy Health has secured $1.1 million in pre-seed funding to improve womens’ pelvic health. Threshold Impact, Beresford Ventures, Equation Angels, Zambon Research Venture, The51, OCI, iGan, and Velocity all participated in the oversubscribed round, along with a…

January 18, 2022 | Alex Muggah

Hamilton Health Sciences Adopts Cloud DX for Post-Surgical Monitoring of 2,400 Patients

Cloud DX has been selected as the Remote Patient Monitoring (RPM) platform for Hamilton Health Sciences (HHS) Surgical Transitions program. Launching this month, the program will monitor selected surgical patient populations using Cloud DX’s Connected Health™ platform supported by HHS’s Virtual Nursing Station. HHS is deploying…

December 15, 2021 | Alex Muggah